OB/Gyn Flashcards
Dysfuncitonal Uterine Bleeding
- Presents as abnormal bleeding with a generally unremarkable PE
- Abnormal uterine bleeding in non-pregnant women
- different from normal cycle in terms of regularity, flow, duration, and volume
- normally occurs right after menarche or during perimenopause
- Causes = PALM-COIEN (polyp, adenomyosis, leiomyoma, malignancy - coag, ovulatory dysFN, endometrial, iatrogenic, not otherwise classified)
- Menorrhagia = heavy or prolonged bleeding
- Metrorrhagia = irregular bleeding between menses
- PE includes speculum, evaluate for bleeding from other sources
Diagnostic studies for DUB
- B-hCG, CBC, iron, PT, PTT, documentation of ovulation, thyroid, serum P, LFTs, PRL, serum FSH
- Pap, US, hysterosalpingography, hysteroscopy, and/or D&C
- endometrial bx should be done on all women over 35yo w/ obesity, HTN, or DM and on all postmenopausal pts
management of DUB (AUB)
- depends on severity of bleeding - may include observation, iron therapy, and volume replacement
- progestin trial - if bleeding stops, anovulatory cylces are confirmed
- OCPs:
- older women w/o risk factors
- OCPs should NOT be used in women over 35 who smoke, have HTN, DM, or hx of vascular dz, breast CA, liver dz, or focal HA
- D&C can be dx and curative
- refractory cases may require endometrial ablation or vaginal hysterectomy
dysmenorrhea general characteristics
- PRIMARY: painful menstruation caused by increased prostaglandin and leukotriene levels - painful uterine cramping, N/V/D
- Onset: usually w/in 2yrs menarche, peak incidence = late teens/early 20s
- THERE IS NO PATHOLOGIC ABNORMALITY
- SECONDARY: painful menstruation caused by identifiable condition (usually uterus or pelvis - endometriosis, adenomyosis, fibroids, PID, IUD)
- usually affects older women (>25yo)
clinical features of dysmenorrhea
- Primary: sxs are central lower abdomen or pelvis radiating to back or thighs, beginning before or at onset of menses, lasting 1-3 days
- PE, labs, radiologic tests = nl
- Secondary: similar sxs as above but may also include bloating, heavy menstrual bleeding, and dyspareunia
- less related to first day of flow
diagnostic studies for dysmenorrhea
- dx of primary dysmenorrhea based on hx, use of menstrual diary, PE
- specific tests for secondary dysmenorrhea - hysteroscopy, D&C, laparoscopy
- all allow both dx and tx
management of dysmenorrhea
- Primary:
- start NSAIDs right before expected menses, continue 2-3 days
- OCPs, vit B (B1, thiamine; B6, pyridoxine), magnesium, acupuncture, heat, regular exercise
- Secondary:
- underlying conditions should be treated
- sx treatment may be sufficient
general characteristics of menopause
- definition: menopause is the last menses, and perimenopause (usually lasting 3-5 yrs) is the time surrounding menopause.
- Dx made: 1 yr of no periods after age 40 with no pathologic cause
- FSH elevated (21-100), estradiol low (<20)
- progesterone levels nl
- mean age = 51.5 yrs
- smoking is associated with early menopause
- premautre menopause (spontanous premature ovarian failure) is cessation of menses before age 40 years
- ovaries continue to produce testosterone and androstenedione; estrone is the predominant postmenopausal circulating estrogen
clinical features of menopause
- vasomotor sxs (hot flashes) vary in intensity - usually resolve in 2-3 yrs (3-6 wks with E tx)
- urogenital atrophy can cause poor vaginal lubrication, dyspareunia, dysuria, urge incontinence, pelvic relaxation, atrophic cystitis, easy bleeding
- accelerated bone loss may cause osteoporosis
- E related cardiovascular protection declines
- changes in sleep cycle
- skin thins, becomes less elastic, facial hair increases, hair loss increases and nails become brittle
- confusion, memory loss, lethargy, depression, loss of sex interest
diagnostic studies for menopause
- FSH of greater than 30 is diagnostic of menopause
management of menopause
- treated on the basis of individual risk factors and sxs
- lifestyle modifications may help sxs, reg exercise can decrease menopausal sxs
- women with INTACT uterus should NOT use E alone (increased risk of endometrial CA)
- combined hormone replacement tx indicated for short-term tx of hot flashes
- can increase risk of CV dz, breast CA, and cognitive changes
- contraindications to hormone tx include undiagnosed vaginal bleeding, acute vascular thrombosis, liver dz, hx of endometrial or breast CA
- Ca and vit D supplementation, bisphosphonates, SERMs, calcitonin all used for osteoporosis
- topical E can improve urogenital sxs
- SSRI and SNRIs (caution with use with tamoxifen)
- soy, black cohosh, and ginseng may also help alleviate sxs
Cervical carcinoma etiology, RF, sxs, dx, tx
- bimodal distribution (35-39; 60-64)
- RF: HPV exposure, early coitarche, multiple sex partners, immunosuppression, SMOKING, low SE status, lack of reg pap smears
- sxs: postcoital bleeding, vaginal bleeding and d/c, dyspareunia
- dx: abnormal cytology, HPV (+), gross lesion
- tx:
- stage 1: conservative, simple, or radical hysterectomy
- stage 2 +: chemo +/- radiation
cervical dysplasia
- MCC: HPV 16 and 18 (18 MC with adenocarcinoma)
- Most HPV infxns regress in 2 yrs
- HPV not enough to cause cancer itself - requires cofacts (smoking, hormones, OCP (>5y), dietary, immunosuppression (lupus), HIV)
- RF: old, AA, low ES, low edu, increased # sex partners, SMOKING, multiparous,, hx of STD
- Indications for conization (LEEP or cold knife):
- unsatisfactory colpo
- +endocerv curettage
- Pap smear indicating adenocarcinoma in situ
- bx that cannot rule out invasive CA
- Discrepancy between pap smear and bx result
cervical cytology results and recommended next steps
- ASCUS (atypical squamous cells of undetermined significance)
- repeat cytology at 6-12 mo
- if both negative, return to routine screening
- if either +, colposcopy
- repeat cytology at 6-12 mo
- AGC (atypical glandular cells of undetermined significance)
- colposcopy with bx of lesions
- LSIL (low-grade intraepithelial lesions)
- colposcopy with bx of lesions
- HSIL (high-grade intraepithelial lesions)
- colposcopy with bx of lesions
Breast cancer RF
- age, sex, first degree relative, BRCA1 or 2
- associated factors: nulliparity, ealry menarche, late menopause, post men ERT or radiation exposure, advanced maternal age at first term birth
- ALL invasive lobular and 2/3 ductal carcinomas are HER2 pos (estrogen-receptor)
Breast CA presentation
- single, nontender, firm, immobile mass
- 45% upper outer quadrant, 25% under nipple and areola
- signs: early, no palpable masses
- rare: nipple d/c, retraction, dimpling, breast enlargement, shrinkage, skin thickening or peau d’orange, eczematous changes, breast pain, fixed mass, axillary node enlargement, ulcerations, arm edema, palpable supraclavicular nodes
Breast CA dx, tx
- dx: any solid dominant breast mass on exam evaluated with FNA or excisional bx
- genetic testing for pts with strong family hx
- axillary lymph node staging with sentinel lymph node bx
- tx: tamoxifen: for estrogen receptor pos dz and postmen women
- adjuvant chemo and hormonal manipulaiton
- lumpectomy with sentinel node bx preferred for early stage
- breast cancer associated with higher risk of endometrial cancer and vice-versa
- axillary lymph node status is the most important prognostic factor for invasive carcinoma in the absence of distant metastasis
chlamydia diagnostics and tx
- Tx: NAAT, wet mount (leukorrhea >10 WBC), culture, enzyme immunoassay, PCR
pagets dz of the breast
- uncommon, ductal carcinoma, presents as eczematous lesions of the nipple
- presentation: eczematoid eruption and ulceration of nipple and areola, pain, itching, burning
- bloody d/c or nipple retraction
- signs: scale, crust, itching, palpable mass (50%)
- dx: full-thickness bx
- tx: local excision, breast conservation with whole breast radiation (if negative margins)
- most are high grade and show HER2 overexpression
Chlamydia etiology and sxs
- Most common bacterial STD
- RF: lack of condom use, lower socioeconomic status, living in an urban area, having multiple sex partners
- most common in F 15-19, then 20-24
- independent risk factor for cervical cancer
- Sxs:
- men: dysuria, purulent urethral discharge, itching, scrotal pain and swelling, fever
- women: puruelnt urethral discharge, intermenstrual or post-coital bleeding, dysuria
- mucopurulent discharge from cervical os, friable cervix
Gonorrhea etiology and sxs
- transmitted sexually or neonatally
- 30% coinfected with chlamydia
- Sxs: asymptomatic in women, symptomatic in men
- Cervicitis or urethritis (purulent discharge, dysuria, intermenstrual bleeding)
- Disseminated: fever, arthralgias, tenosynovitis, septic arthritis, endocarditis, meningitis, skin rash (distal extremities)
Gonorrhea dx and tx
- dx: NAAT, gram stain (leukocytes, gram neg intracell. diplococci), cultures (men from urethra, women from endocervix)
- tx: tx empirically because cultures take 1-2d
- Ceftriaxone x1, add Azithromycin or doxy to cover chlamydia
- if disseminated, hospitalize and IV or IM ceftriaxone
- Complications of dz: PID, infertility, epididymitis, prostatitis, salpingitis, tubo-ovarian abscess, Fitz-Hugh-Curtis syndrome
lymphogranuloma venereum
- MCC: chlamydia trachomatis - primary infxn of lymphatics and lymph nodes
- Sx: hx of proctitis with or without anal lesions
- first stage = painless genital ulcer 3-12d after infxn
- second stage = unilateral lymphadenitis or lymphangitis with tender inguinal or femoral LAD
- Enlarged bubos, which are painful
- Tender lymphadenopathy at the femoral and inguinal lymph nodes, separated by a groove made by poupart ligament (“sign of the groove”)
- dx: serologic testing for syphilis - RPR/VDRL
- Tx: drainage of buboes, doxy 100mg BID x 21d
chancroid
- etiology: haemophilus ducreyi (G-)
- sxs: PAINFUL chancre
- PAINFUL lymphadenopathy - leads to bubo formation
- dysuria and dyspareunia in Fs
- multiple painful punched out ulcer with undermined borders
- dx: serologic testing for syphilis - RPR/VDRL
- culture and gram stain of fluctuant lymph node or ulcer for H ducreyi
- Tx: 1 g azithromycin
- fluctuant inguinal lymph nodes should be incised and drained
HPV
- etiology: MC - condylomata acuminatum
- Low-risk types: 6, 11
- anogenital warts - most common viral STD in US
- Causes nearly 100% of cervical cancers - most significant RF for cervical CA
- Low-risk types: 6, 11
- sxs and signs: most asymptomatic
- flesh-colored papillary exophytic lesions on genitalia
- dx: RPR/VDRL - r/o syphilis
- HIV, HPV viral typing not recommended daily
- Shave or punch bx confirms - hyperplastic prickle cells, koilocytotic or vacuolated squamous epithelial cells in clumps on pap (cervical warts)
- tx: most resolve spontaneously
- podophyllin or trichloroacetic acid
- surgery (cryotherapy, excision, electrocautery, intralesional interferon
- guarasil
- 6, 11 = warts
- 16, 18 = cervical CA
- condoms reduce transmission of warts
Herpes simplex virus (herpes labialis), HSV-1
- transmission: kissing, resides in trigeminal ganglion
- signs and sxs: fever, malaise, vesiculopustular oral lesions in groups
- herpes labialis (cold sores): most common on lips, painful, heal in 2-6 wks
- bell palsy
- herpetic whitlow
- dx: clinical dx with lesions dewdrop on a rose petal
- tzanck smear - multinucleated giant cells
- culture of HSV
- ELISA
- PCR
- tx: acyclovir
- complications: herpes encephalitis, HSV keratitis
Genital herpes, HSV-2
- resides in sacral ganglion
- prior HSV-1 infxn confers partial immunty to HSV2
- signs and sxs: severe, prolonged sxs
- fever, HA, malaise
- painful vesicles on genitals (itching, dysuria, multiple, bilateral)
- tender inguinal lymph nodes
- dx: HSV1 and HSV2 Ab negative
- PCR, culture if active lesion present
- tx: acyclovir, sitz baths, topical xylocaine
- complications: aseptic meningitis, keratitis, blepharitis, keratoconjunctivitis
- C section recommended for pregnant women with active infxn
Pelvic Inflammatory disease etiology and sxs
- etiology: infxn ascends from cervix to involve endometrium and/or fallopian tubes
- MCC = gonorrhea, chlamydia, genital mycoplasmas
- RF: endocervical infxn, BV, hx of PID, vaginal douching, IUD insertion, D&C or C-section
- signs and sxs:
- mucopurulent malodorous vaginal discharge
- abd pain
- abnl vaginal bleeding
- bilateral lower abdominal and pelvic pain
- N/V
- urethritis, proctitis
- Fever
- yellow endocervical discharge, easily induced bleeding
- uterine or adnexal tenderness and swelling, CMT
- rebound/guarding
Pelvic inflammatory disease dx and tx
- Dx: ESR elevated, leukocytosis, B-hCG, NAATs, gram stain
- US: enlarged fallopian tubes with fluid in cul-de-sac
- laparoscopy - last line, rule out appy, ectopic, tumor
- endometrial bx
- outpt: ceftriaxone IM and doxy PO x14d
- +/- flagyl BID x 14d
- inpt: hosp if: dx uncertain, pregnant, abscess suspected, severely ill or N/V preclude outpt management, HIV pos
- Doxy + IV cefotetan or cefoxitin x 48h, then PO doxy BID x14d
- clindamycin + gentamicin qh x48h, then PO doxy BID x14d
trichomoniasis
- signs, sxs: increased d/c and odor, dysuria, frequency, dyspareunia, itching, irritation
- thin yellow-green to gray, adherent frothy discharge in vagina
- malodorous, musty (amine)
- hyperemic mucosa, friable cervix, strawberry cervix (petechiae)
- dx: wet mount, ph 5-6.5 (basic)
- tx: 2 g metronidazole PO x1, no ETOH 48h, TREAT PARTNER
bacterial vaginosis
- MCC vaginitis
- RF: new partner, smoking, IUD, douching, pregnancy
- signs, sxs: mostly asx
- increased vag d/c
- dysuria, frequency, dyspareunia
- noticeable fishy discharge after menses or intercourse, no itching
- thin ivory/gray d/c
- dx: amsel criteria (3 of 4)
- thin, gray, homogenous d/c
- positive whiff
- clue cells
- elevated pH >4.5 (basic)
- tx: metronidazole BID x7d
- Or vaginal metronidazole
atrophic vaginitis
- postmenopausal women, thinning of vag epithelium
- signs, sxs: dyspareunia, thin vag d/c, vag pruritis, burning, soreness
- atrophic vulvar changes (smooth, shiny, pale, dry, thin), scattered vag petechia, thin clear or brown d/c (leukorrhea)
- UTI, urge incontinence may be associated
- Dx: clinical dx
- vaginal cytology (greater % of parabasal cells)
- vaginal pH: 5-7
- tx: H2O soluble lubes, topical vaginal estrogens, oral estrogens
candidiasis
- 2nd MCC vaginitis
- RF: high dose OCP, diaphragm use, DM, abx, pregnant, immune suppression, tight clothes
- signs, sxs: vulvar or vag itching, burning, external dysuria, dyspareunia, odorless thick cottage cheese curd-like d/c
- erythema of vulva, excoriations from scratching
- dx: wet mount - budding yeast
- gram stain - pseudohyphae
- vaginal culture (+) for yeast
- pH <4.7 (acidic)
- tx: fluconazole 150 PO once
- tx uncircumcised partners
- short-course topical azole
- recurrent: weekly topical /PO
- resistant: boric acid TID x7d
primary, secondary, latent, and tertiary syphilis
- TREPONEMA PALLIDUM
- Primary:
- chancre - painless, clean base, 3-4wk after exposure, heals in 14wk w/o light tx, HIGHLY INFXS
- inguinal lymphadenopathy
- Secondary:
- flu-like (HA, fever, sore throat, malaise)
- 4-8 wks after chancre heals, maculopapular rash
- aseptic meningitis
- 1/3 develop latent syphilis
- Latent:
- serological test in absence of clinical sxs
- 2/3 remain asymptomatic
- “early latent” = if serology + for <1 y, may relapse to secondary
- “late latent” = if serology + for >1y, patients are contagious
- Tertiary:
- years after primary infxn
- neurosyphilis, CV syphilis, gummas
- neurosyph: dementia, personality changes, tabes dorsalis (post column degen, loss of corrdination of mvmt)
- rare d/t tx with PCN
Syphilis dx and tx
- Dark field microscopy (GOLD STANDARD)
- Serologic tests (MC)
- Non-treponemal tests: RPR, VDRL
- Treponemal tests: FTA-ABS, MHA-TP
- if FTA-ABS +, check for CSF-FTA-ABS
- test all pts for HIV
- Tx: PCN G (one dse IM)
- doxy and tetra x2wks if PCN allergy
- latent or tertiary: PCN x3 doses IM (1 wk apart)
- neurosyph: IV PCN x 10-14d
- repeat nontreponemal tests q3 mos
- Jarisch-Herxheimer rxn can occur w/ sudden massive destruction of spirochetes - prevent by administering antipyretics during first 24h of tx
- Report to public health agency
breast abscess
- occurs especially during nursing (MC s. aureus)
- presentation: redness, tenderness, induration
- dx: incision and bx if severe or indurated - r/o inflammatory carcinoma
- tx: bactrim, clinda, doxy
breast fibroadenoma
- more common in AA and young (15-35)
- presentation: round, firm (soft, rubbery), painless, freely movable, discrete, mobile
- hormonal relationship: cyclical size
- signs: nontender, unilateral, mobile density, smooth firm mass
- dx: if <30 - US +/- FNA
- if >30 - mammogram
- Excisional bx (if <25), if BRCA + mom
- tx: decrease caffeine
fibrocystic breast dz
- MC benign breast condition (MC 30-50yo)
- Presentation: asx or painful, bilateral, size fluctuation during menstrual cycle
- MULTIPLE LESIONS distinguishes fibrocystic changes from carcinoma
- breast pain, dipple discharge, lumpy and bumpy prior to menses
- signs: tender, bilateral, mobile density, thick gray-green nipple d/c, worse with caffeine intake
- dx: US +/- bx, FNA (diagnostic and tx)
- tx: support bra, decrease caffeine, danazol
- increased risk breast CA when atypia is present
mastitis
- MC in postpartum (2-4th week, S. aureus)
- Presentation: lactating women, FEVER, chills, flu-like, acute, responds to abx
- signs: decreased milk, redness, tenderness, firm mass, breast pain, unlilateral, heat
- dx: culture of purulent material or milk (not routine)
- tx: dicloxacillin (PCN allergy - erythromycin)
- cold compress, NSAIDs and tylenol, continue to breast feed and express milk
cystocele etiology, RF, and sxs
- anterior vaginal prolapse of the posterior bladder wall into the vagina, emerging from the introitus
- pelvic floor injury during childbirth
- RF: genetics, prior prolapse surgery, connective tissue dz, pregnancy, vaginal delivery, parity, advanced age, obesity, menopause, DM, race
- sxs: vaginal bulge or fullness, pressure, heaviness, worse with valsalva
- concurrent urinary incontinence
- incomplete emptying (retention, straining to void (obstruction)
- examine in lithotomy position and standing
- pt must push up bladder in order to void
cystocele dx and tx
- Dx: POP-Q (pelvic organ prolapse quantification), US or MRI, Q-tip test, voiding cystourethrogram, cystometrogram
- tx: pessary, anterior vaginal colporrhaphy, tension-free vaginal tape procedure
- prophylaxis: kegel exercises (strengthen levator ani and perianal mm.), estrogen tx after menopause
rectocele etiology, RF, sxs
- etiology: prolapse of posterior vaginal wall and rectum
- RF: pelvic floor injury during childbirth
- sxs: prolonged, excessive use of laxatives or frequent enemas (constipation)
- introital bulging, concurrent fecal incontinence, constipation, low back pain, dyspareunia
- left decubitus position for detection
- complications: hemorrhoids
rectocele dx, tx
- dx: POP-Q (pelvic organ prolapse quantification), anal manometry, transanal US, MRI, colonoscopy, defocography, EMG
- tx: nonsurgical (use of meds: laxatives, EST), posterior colporrhaphy (repair of posterior fascial defects), colpocleisis (closure) or colpectomy (removal) of the vagina if not sexually active